Acadia Healthcare (NASDAQ:ACHC) Upgraded at StockNews.com

Acadia Healthcare (NASDAQ:ACHC) was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating in a research note issued to investors on Thursday.

A number of other brokerages have also weighed in on ACHC. KeyCorp assumed coverage on shares of Acadia Healthcare in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. Royal Bank of Canada reiterated an “outperform” rating and issued a $94.00 price objective on shares of Acadia Healthcare in a report on Friday, September 20th. Cantor Fitzgerald reissued a “neutral” rating and issued a $90.00 target price on shares of Acadia Healthcare in a research report on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft boosted their target price on shares of Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. Finally, Barclays cut their price objective on shares of Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a research report on Monday, September 30th. Five research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, Acadia Healthcare has a consensus rating of “Moderate Buy” and an average target price of $86.67.

Acadia Healthcare Stock Performance

Acadia Healthcare stock traded down $0.47 during mid-day trading on Thursday, reaching $39.36. The company had a trading volume of 1,148,328 shares, compared to its average volume of 999,576. The company has a 50 day moving average of $58.83 and a 200-day moving average of $65.92. The firm has a market cap of $3.66 billion, a price-to-earnings ratio of 12.90, a PEG ratio of 1.78 and a beta of 1.33. Acadia Healthcare has a 52 week low of $39.27 and a 52 week high of $87.77. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. The business had revenue of $815.60 million during the quarter, compared to analysts’ expectations of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter last year, the company posted $0.91 EPS. On average, sell-side analysts expect that Acadia Healthcare will post 3.38 EPS for the current fiscal year.

Institutional Investors Weigh In On Acadia Healthcare

A number of institutional investors have recently modified their holdings of ACHC. PFM Health Sciences LP raised its stake in Acadia Healthcare by 63.3% during the 3rd quarter. PFM Health Sciences LP now owns 686,150 shares of the company’s stock valued at $43,509,000 after purchasing an additional 265,986 shares during the period. Verition Fund Management LLC bought a new stake in Acadia Healthcare during the 3rd quarter valued at $382,000. Glenmede Trust Co. NA raised its position in shares of Acadia Healthcare by 40.2% in the 3rd quarter. Glenmede Trust Co. NA now owns 5,327 shares of the company’s stock worth $338,000 after acquiring an additional 1,528 shares in the last quarter. BNP Paribas Financial Markets increased its position in Acadia Healthcare by 1,601.3% during the 3rd quarter. BNP Paribas Financial Markets now owns 281,220 shares of the company’s stock valued at $17,832,000 after buying an additional 264,690 shares in the last quarter. Finally, Bank of Montreal Can increased its position in Acadia Healthcare by 2,456.1% during the 3rd quarter. Bank of Montreal Can now owns 324,569 shares of the company’s stock valued at $20,539,000 after buying an additional 311,871 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.